Green Alpha Advisors’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-27,316
| Closed | -$924K | – | 127 |
|
|
2024
Q4 | $924K | Buy |
27,316
+4,107
| +18% | +$139K | 0.74% | 50 |
|
|
2024
Q3 | $949K | Sell |
23,209
-735
| -3% | -$30K | 0.75% | 45 |
|
|
2024
Q2 | $922K | Sell |
23,944
-1,551
| -6% | -$59.7K | 0.74% | 49 |
|
|
2024
Q1 | $1.09M | Buy |
25,495
+7,710
| +43% | +$331K | 0.79% | 46 |
|
|
2023
Q4 | $659K | Sell |
17,785
-5,728
| -24% | -$212K | 0.48% | 87 |
|
|
2023
Q3 | $852K | Buy |
23,513
+2,422
| +11% | +$87.8K | 0.65% | 58 |
|
|
2023
Q2 | $752K | Buy |
21,091
+2,723
| +15% | +$97K | 0.49% | 78 |
|
|
2023
Q1 | $654K | Buy |
18,368
+3,016
| +20% | +$107K | 0.46% | 84 |
|
|
2022
Q4 | $539K | Buy |
15,352
+2,844
| +23% | +$99.9K | 0.45% | 88 |
|
|
2022
Q3 | $368K | Sell |
12,508
-48,928
| -80% | -$1.44M | 0.31% | 119 |
|
|
2022
Q2 | $3.34M | Buy |
+61,436
| New | +$3.34M | 0.77% | 39 |
|